Alexandra Leonard, MD
Dermatology · East Greenwich, RINPI 1538715990
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by AbbVie at 49.6% of the total. Reporting peaked in 2023 at $2,285 and has fallen 99.3% since, to $16 in 2025.
Across 31 payments — averaging $112.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$358
- UCB, Inc.$343
- Janssen Scientific Affairs, LLC$266
- E.r. Squibb & Sons, L.L.C.$170
- Galderma Laboratories, L.p.$144
- plus $477 from 5 others
What the payments were for
- Travel & lodging$1,51944%
- Food & beverage$1,79351%
- Education$1725%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $1,727 |
| Johnson & Johnson | 5 | $358 |
| UCB, Inc. | 3 | $343 |
| Janssen Scientific Affairs, LLC | 2 | $266 |
| E.r. Squibb & Sons, L.L.C. | 2 | $170 |
| Galderma Laboratories, L.p. | 1 | $144 |
| Pfizer | 3 | $129 |
| Boehringer Ingelheim | 1 | $125 |
| Novartis | 1 | $109 |
| Sanofi | 1 | $95 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,485 in reported general payments places this provider in the 70th percentile of 61 dermatology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 180 | $4,027 |
| Fluorouracil | 63 | $3,643 |
| Clobetasol Propionate | 71 | $3,372 |
| Triamcinolone Acetonide | 139 | $1,979 |
| Metronidazole | 11 | $617 |
| Ciclopirox | 11 | $438 |
| Doxycycline Monohydrate | 29 | $431 |
| Mupirocin | 47 | $270 |
| Hydrocortisone | 27 | $206 |
| ValacyclovirValacyclovir Hcl | 15 | $159 |
| Prednisone | 18 | $131 |
| Minoxidil | 17 | $122 |
Paid to pharmacies, not to this prescriber.
Other dermatology in East Greenwich
- John KellyEast Greenwich$97K
- Vincent CriscioneEast Greenwich$8K
- Robert DyerEast Greenwich$3K
- Lynn IlerEast Greenwich$2K
- Anita Pedvis-LeftickEast Greenwich$2K
- Kathleen Carney GodleyEast Greenwich$1K
- Valerie TokarzEast Greenwich$1K
- Paula MoskowitzEast Greenwich$1K
- Julia BaltzEast Greenwich$197
- Caroline ChangEast Greenwich$168
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.